Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Khiron

Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) Q2 2022 total revenue was CA$4.5 million ($3.45 million), up 60% year-over-year, driven by growth in the medical cannabis segment in Colombia and the United Kingdom.

Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe

Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) has completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc. (OTCQB: LMLLF) (CSE:PHRX).

This Week's Cannabis Career Moves: Khiron, Flora Growth, Agrify, Hempsmart And More

This Week's Cannabis Career Moves: Khiron, Flora Growth, Agrify, Hempsmart And More

As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Medical Cannabis Company Khiron Continues Global Expansion Into Spain

Khiron Life Sciences Corp.

Meet Alvaro Torres, CEO Of Lat Am & UK's Top Medical Marijuana Brand At Benzinga's Cannabis Capital Conference In September

After a prosperous Miami event this past April, the Benzinga Cannabis Capital Conference will take place in Chicago on September 13-14. As always, the meeting will host leading executives and investors who will talk about the industry’s present and future.

Khiron Reveals Results Of 2022 Annual General And Special Meeting

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, revealed the results of its 2022 annual general and special meeting of shareholders held on June 23, 2022.

Khiron To Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer And Wholesaler

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. (CSE:PHRX) (OTCQB: LMLLF).

inkl

Read news from The Economist, FT, and more,
with one subscription

Khiron Life Sciences Q1 2022 Financial Results Show Record Revenue In Medical Cannabis

Khiron Life Sciences Q1 2022 Financial Results Show Record Revenue In Medical Cannabis

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV: KHRN) (Frankfurt: A2JMZC) released its financial results for the quarter ended March 31, 2022, revealing record revenue in the medical cannabis business.

Khiron Reports Revenue Growth Of 59.6% In 2021, Gross Profit Improves 230% YoY

Khiron Reports Revenue Growth Of 59.6% In 2021, Gross Profit Improves 230% YoY

Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC) released its financial results for the year ended and quarter ended December 31, 2021. 2021 Financial Highlights:

Cannabis Dispensary Roundup: Where To Buy Rec Marijuana In New Jersey, CBD Spas & More Store Openings

Cannabis Dispensary Roundup: Where To Buy Rec Marijuana In New Jersey, CBD Spas & More Store Openings

New Jersey legal recreational cannabis sales will launch on April 21, after a series of setbacks and 17 months after New Jerseyans chose to legalize the use of recreational cannabis in a ballot measure.

Khiron Opens New Zerenia Clinic And Medical Cannabis Pharmacy In Colombia

Khiron Opens New Zerenia Clinic And Medical Cannabis Pharmacy In Colombia

Khiron Life Sciences Corp. (OTCQX:KHRNF) (TSXV:KHRN)(Frankfurt:A2JMZC) is opening a new Zerenia clinic location and a new retail pharmacy in Colombia.

How Efficient Is Medicinal Cannabis As Treatment For Chronic Pain? Khiron's Clinical Study Reveals

How Efficient Is Medicinal Cannabis As Treatment For Chronic Pain? Khiron's Clinical Study Reveals

Khiron Life Sciences Corp. (OTCQX:KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC) has published in the international peer-reviewed journal Frontiers in Pain Research the results of its first clinical study on the use of medical cannabis prescribed to Colombian patients in treating chronic pain. This is the first published clinical evidence on the effectiveness…

EXCLUSIVE: Medical Cannabis Innovator Khiron Partners With Health Care Company Teleton In Mexico

EXCLUSIVE: Medical Cannabis Innovator Khiron Partners With Health Care Company Teleton In Mexico

Medical cannabis company Khiron Life Sciences Corp.(TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC) has partnered with health care company Teleton to bring access to medical cannabis to more than 24 medical centers across Mexico.

Khiron Adds Another Clinic Location In Peru In Partnership With Pain Clinic CDL

Khiron Adds Another Clinic Location In Peru In Partnership With Pain Clinic CDL

Medical marijuana company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) is opening another Zerenia location in Peru in partnership with the renowned pain clinic, CDL. Khiron In Peru Highlights

Get all your
news in one place.

100’s of premium titles.
One news app.

Cannabis Dispensary Roundup: Cresco Labs, High Tide, Khiron, Cordova Cann

Cresco Labs Opens 14th Florida Medical Cannabis Dispensary

Khiron Stock Spikes After Announcing Opening Another Medical Cannabis Clinic In Colombia

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Benzinga Cannabis Capital Conference

Khiron Life Sciences Corp

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

290,217 stories

117,746 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play